Zydus Life Sciences is engaged in a legal battle with Roche over its biosimilar, Sigrima, which is based on Roche’s Perjeta (Pertuzumab), targeting the human epidermal growth factor receptor 2-positive (HER2+) breast cancer market in India.
The benefit of Eisai and Biogen’s Alzheimer’s drug Leqembi in patients with early-stage Alzheimer’s appears to increase with continued use with no new safety issues, according to three-year data presented at an Alzheimer’s meeting on Tuesday.
AgencyOS is the first AI offering from the agency through an ongoing partnership with PixieDust Labs, a leader in machine learning and integrated AI marketing solutions.
Adding to growing evidence of its benefits beyond glucose control and weight loss, Novo Nordisk’s Ozempic could also potentially help diabetics quit smoking, according to new research.
Although the company is dealing with a sharp revenue drop from COVID products, it raised its annual profit forecast on Tuesday, helped by new cancer treatments acquired through its $43 billion deal for Seagen and strong sales of its heart disease drug.
While questions remain surrounding the accessibility of lenacapavir, the drug holds greater potential for reducing the global incidence of HIV than any other to date, says GlobalData.